Analysed VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) News Sources
Vanda Pharmaceuticals Announces Participation at September 2026 Investor Conferences
02-09-2026
yahoo.com
Vanda Pharmaceuticals Announces Positive Phase III Results for HETLIOZ®(tasimelteon) in Delayed Sleep-Wake Phase Disorder
29-09-2026
yahoo.com
Biotech Lagged The Broader Market In September — Did Retail Favorites SLS, IBRX, VNDA And IOVA Dodge XBI’s Slump?
30-09-2026
stocktwits.com
Vanda puts anxiety drug’s development on ice after Phase III fail
15-10-2026
clinicaltrialsarena.com
Vanda Pharmaceuticals to Announce Third Quarter 2026 Financial Results on October 28, 2026
21-10-2026
yahoo.com
What is the current price of VANDA PHARMACEUTICALS INC (VNDA:NASDAQ)?
The current price of VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) is $3.99.
VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) absolute price change since previous trading day?
The absolute price change of VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) since the previous trading day is $0.05.
VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) percentage price change since previous trading day?
The percentage price change of VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) since the previous trading day is 1.269%.
What is the most recent average sentiment score for VANDA PHARMACEUTICALS INC (VNDA:NASDAQ)?
The most recent average sentiment score for VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for VANDA PHARMACEUTICALS INC (VNDA:NASDAQ)?
The most recent sentiment for VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) is .
SEC-8K** Filing Available For VANDA PHARMACEUTICALS INC (VNDA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.